Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 415

1.

Medical imaging dose optimization from ground up: expert opinion of an international summit.

Samei E, Jarvinen H, Kortesniemi M, Simantirakis G, Goh C, Wallace A, Vano E, Bejan A, Rehani MM, Vassileva J.

J Radiol Prot. 2018 May 17. doi: 10.1088/1361-6498/aac575. [Epub ahead of print]

PMID:
29769433
2.

Patient safety in external beam radiotherapy, results of the ACCIRAD project: Recommendations for radiotherapy institutions and national authorities on assessing risks and analysing adverse error-events and near misses.

Malicki J, Bly R, Bulot M, Godet JL, Jahnen A, Krengli M, Maingon P, Prieto Martin C, Skrobala A, Valero M, Jarvinen H.

Radiother Oncol. 2018 May 2. pii: S0167-8140(18)30194-4. doi: 10.1016/j.radonc.2018.04.006. [Epub ahead of print]

PMID:
29729846
3.

Feasibility of setting up generic alert levels for maximum skin dose in fluoroscopically guided procedures.

Jarvinen H, Farah J, Siiskonen T, Ciraj-Bjelac O, Dabin J, Carinou E, Domienik-Andrzejewska J, Kluszczynski D, Knežević Ž, Kopec R, Majer M, Malchair F, Negri A, Pankowski P, Sarmento S, Trianni A.

Phys Med. 2018 Feb;46:67-74. doi: 10.1016/j.ejmp.2018.01.010.

PMID:
29519411
4.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report.

Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Frayling IM, Plazzer JP, Sampson JR, Capella G, Möslein G, Mecklin JP, Møller P; Mallorca Group.

Hered Cancer Clin Pract. 2017 Oct 10;15:18. doi: 10.1186/s13053-017-0078-5. eCollection 2017.

5.

Patient dose monitoring and the use of diagnostic reference levels for the optimization of protection in medical imaging: current status and challenges worldwide.

Järvinen H, Vassileva J, Samei E, Wallace A, Vano E, Rehani M.

J Med Imaging (Bellingham). 2017 Jul;4(3):031214. doi: 10.1117/1.JMI.4.3.031214. Epub 2017 Oct 4.

PMID:
29021989
6.

Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.

Tanskanen T, van den Berg L, Välimäki N, Aavikko M, Ness-Jensen E, Hveem K, Wettergren Y, Bexe Lindskog E, Tõnisson N, Metspalu A, Silander K, Orlando G, Law PJ, Tuupanen S, Gylfe AE, Hänninen UA, Cajuso T, Kondelin J, Sarin AP, Pukkala E, Jousilahti P, Salomaa V, Ripatti S, Palotie A, Järvinen H, Renkonen-Sinisalo L, Lepistö A, Böhm J, Mecklin JP, Al-Tassan NA, Palles C, Martin L, Barclay E, Tenesa A, Farrington SM, Timofeeva MN, Meyer BF, Wakil SM, Campbell H, Smith CG, Idziaszczyk S, Maughan TS, Kaplan R, Kerr R, Kerr D, Buchanan DD, Win AK, Hopper J, Jenkins MA, Newcomb PA, Gallinger S, Conti D, Schumacher FR, Casey G, Cheadle JP, Dunlop MG, Tomlinson IP, Houlston RS, Palin K, Aaltonen LA.

Int J Cancer. 2018 Feb 1;142(3):540-546. doi: 10.1002/ijc.31076. Epub 2017 Oct 12.

PMID:
28960316
7.

Excess of Radiation Burden for Young Testicular Cancer Patients using Automatic Exposure Control and Contrast Agent on Whole-body Computed Tomography Imaging.

Niiniviita H, Kulmala J, Pölönen T, Määttänen H, Järvinen H, Salminen E.

Radiol Oncol. 2017 Feb 26;51(2):235-240. doi: 10.1515/raon-2017-0012. eCollection 2017 Jun.

8.

Correction: Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.

Nissilä E, Douillard FP, Ritari J, Paulin L, Järvinen HM, Rasinkangas P, Haapasalo K, Meri S, Jarva H, de Vos WM.

PLoS One. 2017 Jul 10;12(7):e0181292. doi: 10.1371/journal.pone.0181292. eCollection 2017.

9.

Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome.

Renkonen-Sinisalo L, Seppälä TT, Järvinen HJ, Mecklin JP.

Dis Colon Rectum. 2017 Aug;60(8):792-799. doi: 10.1097/DCR.0000000000000802.

PMID:
28682964
10.

Comprehensive Evaluation of Protein Coding Mononucleotide Microsatellites in Microsatellite-Unstable Colorectal Cancer.

Kondelin J, Gylfe AE, Lundgren S, Tanskanen T, Hamberg J, Aavikko M, Palin K, Ristolainen H, Katainen R, Kaasinen E, Taipale M, Taipale J, Renkonen-Sinisalo L, Järvinen H, Böhm J, Mecklin JP, Vahteristo P, Tuupanen S, Aaltonen LA, Pitkänen E.

Cancer Res. 2017 Aug 1;77(15):4078-4088. doi: 10.1158/0008-5472.CAN-17-0682. Epub 2017 Jun 13.

PMID:
28611049
11.

Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system.

Nissilä E, Douillard FP, Ritari J, Paulin L, Järvinen HM, Rasinkangas P, Haapasalo K, Meri S, Jarva H, de Vos WM.

PLoS One. 2017 May 11;12(5):e0176739. doi: 10.1371/journal.pone.0176739. eCollection 2017. Erratum in: PLoS One. 2017 Jul 10;12 (7):e0181292.

12.

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei.

Saarinen L, Nummela P, Thiel A, Lehtonen R, Järvinen P, Järvinen H, Aaltonen LA, Lepistö A, Hautaniemi S, Ristimäki A.

PLoS One. 2017 Apr 20;12(4):e0174898. doi: 10.1371/journal.pone.0174898. eCollection 2017.

13.

Patient safety in external beam radiotherapy, results of the ACCIRAD project: Current status of proactive risk assessment, reactive analysis of events, and reporting and learning systems in Europe.

Malicki J, Bly R, Bulot M, Godet JL, Jahnen A, Krengli M, Maingon P, Prieto Martin C, Przybylska K, Skrobała A, Valero M, Jarvinen H.

Radiother Oncol. 2017 Apr;123(1):29-36. doi: 10.1016/j.radonc.2017.02.016. Epub 2017 Mar 25.

PMID:
28351525
14.

Cancer Death Risk Related to Radiation Exposure from Computed Tomography Scanning Among Testicular Cancer Patients.

Salminen E, Niiniviita H, Järvinen H, Heinävaara S.

Anticancer Res. 2017 Feb;37(2):831-834.

PMID:
28179338
15.

Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease.

Orlando G, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen UA, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E, Sarin AP, Kaprio J, Eriksson JG, Rissanen H, Knekt P, Pukkala E, Jousilahti P, Salomaa V, Ripatti S, Palotie A, Järvinen H, Renkonen-Sinisalo L, Lepistö A, Böhm J, Mecklin JP, Al-Tassan NA, Palles C, Martin L, Barclay E, Tenesa A, Farrington S, Timofeeva MN, Meyer BF, Wakil SM, Campbell H, Smith CG, Idziaszczyk S, Maughan TS, Kaplan R, Kerr R, Kerr D, Buchanan DD, Win AK, Hopper J, Jenkins M, Lindor NM, Newcomb PA, Gallinger S, Conti D, Schumacher F, Casey G, Taipale J, Cheadle JP, Dunlop MG, Tomlinson IP, Aaltonen LA, Houlston RS.

Hum Mol Genet. 2016 Jun 1;25(11):2349-2359. Epub 2016 Mar 22.

16.

Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis.

Nieminen TT, Pavicic W, Porkka N, Kankainen M, Järvinen HJ, Lepistö A, Peltomäki P.

Oncotarget. 2016 Oct 25;7(43):70685-70698. doi: 10.18632/oncotarget.12206.

17.

Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer.

Jarvis D, Mitchell JS, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen UA, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E, Sarin AP, Kaprio J, Eriksson JG, Rissanen H, Knekt P, Pukkala E, Jousilahti P, Salomaa V, Ripatti S, Palotie A, Järvinen H, Renkonen-Sinisalo L, Lepistö A, Böhm J, Meklin JP, Al-Tassan NA, Palles C, Martin L, Barclay E, Farrington SM, Timofeeva MN, Meyer BF, Wakil SM, Campbell H, Smith CG, Idziaszczyk S, Maughan TS, Kaplan R, Kerr R, Kerr D, Buchanan DD, Win AK, Hopper JL, Jenkins MA, Lindor NM, Newcomb PA, Gallinger S, Conti D, Schumacher F, Casey G, Taipale J, Aaltonen LA, Cheadle JP, Dunlop MG, Tomlinson IP, Houlston RS.

Br J Cancer. 2016 Jul 12;115(2):266-72. doi: 10.1038/bjc.2016.188. Epub 2016 Jun 23.

18.

The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription.

Abdel-Rahman WM, Lotsari-Salomaa JE, Kaur S, Niskakoski A, Knuutila S, Järvinen H, Mecklin JP, Peltomäki P.

Gastroenterol Res Pract. 2016;2016:6089658. doi: 10.1155/2016/6089658. Epub 2016 Mar 7.

19.

Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei.

Nummela P, Leinonen H, Järvinen P, Thiel A, Järvinen H, Lepistö A, Ristimäki A.

Hum Pathol. 2016 Aug;54:47-54. doi: 10.1016/j.humpath.2016.02.022. Epub 2016 Mar 30.

PMID:
27038681
20.

[Diagnosis and treatment of Lynch syndrome].

Seppälä T, Pylvänäinen K, Renkonen-Sinisalo L, Böhm J, Kuopio T, Järvinen HJ, Mecklin JP.

Duodecim. 2016;132(3):233-40. Review. Finnish.

PMID:
26951027
21.

Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland.

Pitkäniemi J, Seppä K, Hakama M, Malminiemi O, Palva T, Vuoristo MS, Järvinen H, Paimela H, Pikkarainen P, Anttila A, Elovainio L, Hakulinen T, Karjalainen S, Pylkkänen L, Rautalahti M, Sarkeala T, Vertio H, Malila N.

BMJ Open Gastroenterol. 2015 Jun 8;2(1):e000034. doi: 10.1136/bmjgast-2015-000034. eCollection 2015.

22.

Characterisation of grids of point detectors in maximum skin dose measurement in fluoroscopically-guided interventional procedures.

Dabin J, Negri A, Farah J, Ciraj-Bjelac O, Clairand I, De Angelis C, Domienik J, Jarvinen H, Kopec R, Majer M, Malchair F, Novák L, Siiskonen T, Vanhavere F, Trianni A, Knežević Ž.

Phys Med. 2015 Dec;31(8):1112-1117. doi: 10.1016/j.ejmp.2015.08.006. Epub 2015 Oct 4.

PMID:
26439858
23.

Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.

Kämpjärvi K, Kim NH, Keskitalo S, Clark AD, von Nandelstadh P, Turunen M, Heikkinen T, Park MJ, Mäkinen N, Kivinummi K, Lintula S, Hotakainen K, Nevanlinna H, Hokland P, Böhling T, Bützow R, Böhm J, Mecklin JP, Järvinen H, Kontro M, Visakorpi T, Taipale J, Varjosalo M, Boyer TG, Vahteristo P.

Prostate. 2016 Jan;76(1):22-31. doi: 10.1002/pros.23092. Epub 2015 Sep 18.

PMID:
26383637
24.

DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas.

Valo S, Kaur S, Ristimäki A, Renkonen-Sinisalo L, Järvinen H, Mecklin JP, Nyström M, Peltomäki P.

Clin Epigenetics. 2015 Jul 22;7:71. doi: 10.1186/s13148-015-0102-4. eCollection 2015.

25.

Characterization of XR-RV3 GafChromic(®) films in standard laboratory and in clinical conditions and means to evaluate uncertainties and reduce errors.

Farah J, Trianni A, Ciraj-Bjelac O, Clairand I, De Angelis C, Delle Canne S, Hadid L, Huet C, Jarvinen H, Negri A, Novák L, Pinto M, Siiskonen T, Waryn MJ, Knežević Ž.

Med Phys. 2015 Jul;42(7):4211-26. doi: 10.1118/1.4922132.

PMID:
26133620
26.

Human population dynamics in Europe over the Last Glacial Maximum.

Tallavaara M, Luoto M, Korhonen N, Järvinen H, Seppä H.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8232-7. doi: 10.1073/pnas.1503784112. Epub 2015 Jun 22.

27.

CTCF/cohesin-binding sites are frequently mutated in cancer.

Katainen R, Dave K, Pitkänen E, Palin K, Kivioja T, Välimäki N, Gylfe AE, Ristolainen H, Hänninen UA, Cajuso T, Kondelin J, Tanskanen T, Mecklin JP, Järvinen H, Renkonen-Sinisalo L, Lepistö A, Kaasinen E, Kilpivaara O, Tuupanen S, Enge M, Taipale J, Aaltonen LA.

Nat Genet. 2015 Jul;47(7):818-21. doi: 10.1038/ng.3335. Epub 2015 Jun 8.

PMID:
26053496
28.

3'-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity.

Kondelin J, Tuupanen S, Gylfe AE, Aavikko M, Renkonen-Sinisalo L, Järvinen H, Böhm J, Mecklin JP, Andersen CL, Vahteristo P, Pitkänen E, Aaltonen LA.

Fam Cancer. 2015 Sep;14(3):449-53. doi: 10.1007/s10689-015-9804-1.

PMID:
25930744
29.

Collective effective dose in Europe from X-ray and nuclear medicine procedures.

Bly R, Jahnen A, Järvinen H, Olerud H, Vassileva J, Vogiatzi S.

Radiat Prot Dosimetry. 2015 Jul;165(1-4):129-32. doi: 10.1093/rpd/ncv094. Epub 2015 Apr 5.

PMID:
25848115
30.

Indication-based national diagnostic reference levels for paediatric CT: a new approach with proposed values.

Järvinen H, Seuri R, Kortesniemi M, Lajunen A, Hallinen E, Savikurki-Heikkilä P, Laarne P, Perhomaa M, Tyrväinen E.

Radiat Prot Dosimetry. 2015 Jul;165(1-4):86-90. doi: 10.1093/rpd/ncv044. Epub 2015 Apr 1.

PMID:
25833898
31.

Analysis of factors correlating with medical radiological examination frequencies.

Jahnen A, Järvinen H, Olerud H, Vassilieva J, Vogiatzi S, Shannoun F, Bly R.

Radiat Prot Dosimetry. 2015 Jul;165(1-4):133-6. doi: 10.1093/rpd/ncv041. Epub 2015 Mar 25.

PMID:
25813479
32.

Systematic search for rare variants in Finnish early-onset colorectal cancer patients.

Tanskanen T, Gylfe AE, Katainen R, Taipale M, Renkonen-Sinisalo L, Järvinen H, Mecklin JP, Böhm J, Kilpivaara O, Pitkänen E, Palin K, Vahteristo P, Tuupanen S, Aaltonen LA.

Cancer Genet. 2015 Jan-Feb;208(1-2):35-40. doi: 10.1016/j.cancergen.2014.12.004. Epub 2014 Dec 31.

PMID:
25749350
33.

Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.

Niskakoski A, Kaur S, Staff S, Renkonen-Sinisalo L, Lassus H, Järvinen HJ, Mecklin JP, Bützow R, Peltomäki P.

Epigenetics. 2014 Dec;9(12):1577-87. doi: 10.4161/15592294.2014.983374.

34.

Costs of colorectal cancer in different states of the disease.

Färkkilä N, Torvinen S, Sintonen H, Saarto T, Järvinen H, Hänninen J, Taari K, Roine RP.

Acta Oncol. 2015 Apr;54(4):454-62. doi: 10.3109/0284186X.2014.985797. Epub 2014 Dec 18.

PMID:
25519708
35.

Comparison of proctocolectomy and ileal pouch-anal anastomosis to colectomy and ileorectal anastomosis in familial adenomatous polyposis.

Koskenvuo L, Mustonen H, Renkonen-Sinisalo L, Järvinen HJ, Lepistö A.

Fam Cancer. 2015 Jun;14(2):221-7. doi: 10.1007/s10689-014-9773-9.

PMID:
25504366
36.

Reply: To PMID 24941021.

Nieminen TT, Mecklin JP, Järvinen HJ, Peltomäki P.

Gastroenterology. 2015 Jan;148(1):259. doi: 10.1053/j.gastro.2014.11.028. Epub 2014 Nov 22. No abstract available.

PMID:
25451653
37.

Measurement of maximum skin dose in interventional radiology and cardiology and challenges in the set-up of European alert thresholds.

Farah J, Trianni A, Carinou E, Ciraj-Bjelac O, Clairand I, Dabin J, De Angelis C, Domienik J, Jarvinen H, Kopec R, Majer M, Malchair F, Negri A, Novák L, Siiskonen T, Vanhavere F, Knežević Ž.

Radiat Prot Dosimetry. 2015 Apr;164(1-2):138-42. doi: 10.1093/rpd/ncu314. Epub 2014 Oct 14.

PMID:
25316909
38.

Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry.

Nummela P, Saarinen L, Thiel A, Järvinen P, Lehtonen R, Lepistö A, Järvinen H, Aaltonen LA, Hautaniemi S, Ristimäki A.

Int J Cancer. 2015 Mar 1;136(5):E282-9. doi: 10.1002/ijc.29245. Epub 2014 Oct 13.

39.

Patient safety in external beam radiotherapy - guidelines on risk assessment and analysis of adverse error-events and near misses: introducing the ACCIRAD project.

Malicki J, Bly R, Bulot M, Godet JL, Jahnen A, Krengli M, Maingon P, Martin CP, Przybylska K, Skrobała A, Valero M, Jarvinen H.

Radiother Oncol. 2014 Aug;112(2):194-8. doi: 10.1016/j.radonc.2014.08.011. Epub 2014 Sep 19.

PMID:
25245556
40.

Identification of 33 candidate oncogenes by screening for base-specific mutations.

Tuupanen S, Hänninen UA, Kondelin J, von Nandelstadh P, Cajuso T, Gylfe AE, Katainen R, Tanskanen T, Ristolainen H, Böhm J, Mecklin JP, Järvinen H, Renkonen-Sinisalo L, Andersen CL, Taipale M, Taipale J, Vahteristo P, Lehti K, Pitkänen E, Aaltonen LA.

Br J Cancer. 2014 Oct 14;111(8):1657-62. doi: 10.1038/bjc.2014.429. Epub 2014 Aug 12.

41.

Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.

Kämpjärvi K, Park MJ, Mehine M, Kim NH, Clark AD, Bützow R, Böhling T, Böhm J, Mecklin JP, Järvinen H, Tomlinson IP, van der Spuy ZM, Sjöberg J, Boyer TG, Vahteristo P.

Hum Mutat. 2014 Sep;35(9):1136-41. doi: 10.1002/humu.22612. Epub 2014 Jul 21.

PMID:
24980722
42.

Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin.

Järvinen P, Ristimäki A, Kantonen J, Aronen M, Huuhtanen R, Järvinen H, Lepistö A.

Int J Colorectal Dis. 2014 Aug;29(8):999-1007. doi: 10.1007/s00384-014-1933-8. Epub 2014 Jun 26.

PMID:
24965858
43.

Promoter-specific alterations of APC are a rare cause for mutation-negative familial adenomatous polyposis.

Pavicic W, Nieminen TT, Gylling A, Pursiheimo JP, Laiho A, Gyenesei A, Järvinen HJ, Peltomäki P.

Genes Chromosomes Cancer. 2014 Oct;53(10):857-64. doi: 10.1002/gcc.22197. Epub 2014 Jun 20.

PMID:
24946964
44.

Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.

Nieminen TT, O'Donohue MF, Wu Y, Lohi H, Scherer SW, Paterson AD, Ellonen P, Abdel-Rahman WM, Valo S, Mecklin JP, Järvinen HJ, Gleizes PE, Peltomäki P.

Gastroenterology. 2014 Sep;147(3):595-598.e5. doi: 10.1053/j.gastro.2014.06.009. Epub 2014 Jun 15.

45.

Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.

Cajuso T, Hänninen UA, Kondelin J, Gylfe AE, Tanskanen T, Katainen R, Pitkänen E, Ristolainen H, Kaasinen E, Taipale M, Taipale J, Böhm J, Renkonen-Sinisalo L, Mecklin JP, Järvinen H, Tuupanen S, Kilpivaara O, Vahteristo P.

Int J Cancer. 2014 Aug 1;135(3):611-23. doi: 10.1002/ijc.28705. Epub 2014 Jan 13.

46.

Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis.

Koskenvuo L, Renkonen-Sinisalo L, Järvinen HJ, Lepistö A.

Int J Colorectal Dis. 2014 Feb;29(2):225-30. doi: 10.1007/s00384-013-1796-4. Epub 2013 Nov 30.

PMID:
24292488
47.

Eleven candidate susceptibility genes for common familial colorectal cancer.

Gylfe AE, Katainen R, Kondelin J, Tanskanen T, Cajuso T, Hänninen U, Taipale J, Taipale M, Renkonen-Sinisalo L, Järvinen H, Mecklin JP, Kilpivaara O, Pitkänen E, Vahteristo P, Tuupanen S, Karhu A, Aaltonen LA.

PLoS Genet. 2013;9(10):e1003876. doi: 10.1371/journal.pgen.1003876. Epub 2013 Oct 17.

48.

Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG.

Douillard FP, Ribbera A, Kant R, Pietilä TE, Järvinen HM, Messing M, Randazzo CL, Paulin L, Laine P, Ritari J, Caggia C, Lähteinen T, Brouns SJ, Satokari R, von Ossowski I, Reunanen J, Palva A, de Vos WM.

PLoS Genet. 2013;9(8):e1003683. doi: 10.1371/journal.pgen.1003683. Epub 2013 Aug 15.

49.

Fibrinolytic and coagulative activities of Yersinia pestis.

Korhonen TK, Haiko J, Laakkonen L, Järvinen HM, Westerlund-Wikström B.

Front Cell Infect Microbiol. 2013 Jul 26;3:35. doi: 10.3389/fcimb.2013.00035. eCollection 2013. Review.

50.

Human single-chain urokinase is activated by the omptins PgtE of Salmonella enterica and Pla of Yersinia pestis despite mutations of active site residues.

Järvinen HM, Laakkonen L, Haiko J, Johansson T, Juuti K, Suomalainen M, Buchrieser C, Kalkkinen N, Korhonen TK.

Mol Microbiol. 2013 Aug;89(3):507-17. doi: 10.1111/mmi.12293. Epub 2013 Jul 11.

Supplemental Content

Loading ...
Support Center